CELLTRION

Celltrion, Inc.

Application Filed: 2009-11-10
Trademark Application Details
Trademark Logo CELLTRION

Mark For: CELLTRION® trademark registration is intended to cover the categories of [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]. [all]

Status

2020-06-01 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number79079370
Registration Number3936764
Mark Literal ElementsCELLTRION
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Affidavit TextSECTION 71
Current LocationNot Found 2017-06-15
Basis66(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentYes
Current BasisNo
No BasisNo
Cancellation CodeG
Domestic RepresentativeDan S. Cohn
Attorney NameDan S. Cohn
Attorney Docket Number504478.16
Law Office AssignedM20
Employee NameEULIN, INGRID C

Timeline

2009-11-10Application Filed
2011-01-11Published
2011-01-11Published for Opposition
2011-03-29Trademark Registered
2017-06-15Location:
2017-06-15Location: Not Found
2017-06-15Status: A partial Section 71 declaration has been accepted.
2017-06-15Status: Live/Registered
2019-12-05Transaction Date
2021-03-29Maintenance On Time Date
2021-09-29Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: CELLTRION, INC.
Address23, Academy-ro, Yeonsu-gu Incheon KOREA, REPUBLIC OF 406840
Legal Entity TypeLimited Company
Legal Entity StateKOREA, REPUBLIC OF

Attorney of Record

Dan S. Cohn
Husch Blackwell LLP
190 Carondelet Plaza, Suite 600
St. Louis MO 63015

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
IC 035. US 100 101 102. G & S: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
IC 040. US 100 103 106. G & S: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
IC 042. US 100 101. G & S: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ](CANCELLED)
IC 044. US 100 101. G & S: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service]

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:35
U.S. Codes:100,101,102
International Codes:40
U.S. Codes:100,103,106
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051[ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]

Assignments

Trademark Filing History

DescriptionDateProceeding Number
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED2020-03-29
INTERNATIONAL REGISTRATION RENEWED2019-12-05
PARTIAL INVALIDATION PROCESSED BY THE IB2018-04-06
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB2018-02-22
INVALIDATION PROCESSED2018-02-2267445
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED2018-02-15
REGISTERED - PARTIAL SEC 71 ACCEPTED2017-06-1576874
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED2017-06-15
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2017-06-1576874
TEAS SECTION 71 RECEIVED2017-03-28
CHANGE OF NAME/ADDRESS REC'D FROM IB2015-03-26
FINAL DECISION TRANSACTION PROCESSED BY IB2013-02-25
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED2012-06-1272589
LIMITATION OF GOODS RECEIVED FROM IB2012-05-25
FINAL DISPOSITION PROCESSED2011-06-3067445
FINAL DISPOSITION NOTICE SENT TO IB2011-06-30
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2011-06-29
REGISTERED-PRINCIPAL REGISTER2011-03-29
PUBLISHED FOR OPPOSITION2011-01-11
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2011-01-11
LAW OFFICE PUBLICATION REVIEW COMPLETED2010-12-0773797
ASSIGNED TO LIE2010-12-0773797
APPROVED FOR PUB - PRINCIPAL REGISTER2010-11-15
TEAS/EMAIL CORRESPONDENCE ENTERED2010-11-1288889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2010-11-11
TEAS CHANGE OF CORRESPONDENCE RECEIVED2010-11-11
CORRESPONDENCE RECEIVED IN LAW OFFICE2010-11-1188889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2010-05-126325
NON-FINAL ACTION WRITTEN2010-05-1276839
NON-FINAL ACTION E-MAILED2010-05-126325
TEAS/EMAIL CORRESPONDENCE ENTERED2010-05-1088889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2010-05-10
TEAS CHANGE OF CORRESPONDENCE RECEIVED2010-05-10
CORRESPONDENCE RECEIVED IN LAW OFFICE2010-05-1088889
UNDELIVERABLE MAIL - NO ACTION TAKEN2010-04-1999888
REFUSAL PROCESSED BY IB2010-04-09
APPLICATION FILING RECEIPT MAILED2010-03-19
REFUSAL PROCESSED BY MPU2010-03-1768359
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2010-03-17
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2010-03-17
NON-FINAL ACTION WRITTEN2010-03-1676839
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2010-03-15
ASSIGNED TO EXAMINER2010-03-1576839
SN ASSIGNED FOR SECT 66A APPL FROM IB2010-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed